Press Release May 29, 2023 Refractory Metastatic Melanoma Market expected to rise, Idera Pharmaceuticals, Bristol-Myers Squibb, Sunesin Pharmaceuticals, Taiga biotechnologies, BioNtech, expected to drive market
Press Release May 29, 2023 Refractory Status Epilepticus Market expected to rise, Sage Therapeutics, Marinus Pharmaceuticals, Veriton Pharma, expected to drive market
Press Release May 29, 2023 Relapsed Chronic Lymphocytic Leukemia Market expected to rise, Bristol-Myers Squibb, Aptevo Therapeutics, Novartis Pharmaceuticals, expected to drive market
Press Release May 29, 2023 Relapsed or Refractory Mycosis Fungoides Market expected to rise, Acrotech Biopharma, Millennium Pharmaceuticals, Affimed GmbH, expected to drive market
Press Release May 29, 2023 Relapsed or Refractory Myelodysplastic Syndrome Market expected to rise, Cantex Pharmaceuticals, Newave Pharmaceuticals, BioTheryX, expected to drive market
Press Release May 29, 2023 Relapsed/Refractory Epstein Barr Virus Market expected to rise, Viracta Therapeutics, Atara Biotherapeutics, and AlloVir, expected to drive market
Press Release May 29, 2023 Relapsing Multiple Sclerosis Market expected to Rise | Companies – Novartis, Sanofi, Cinnagen, Polpharma Biologics, Immunic, Mapi Pharma, Biocad, Apimeds, Genentech (Roche), Merck
Press Release May 29, 2023 Rosacea Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Accuitis, AOBiome, CAGE Bio Inc., LEO Pharma, Dr. Reddy’s Laboratories, Alfasigma S.p.A.
Press Release May 29, 2023 Nonmelanoma Skin Cancer Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Sirnaomics, AiViva BioPharma, Replimune, Salzburger Landeskliniken, Bristol
Press Release May 29, 2023 Sarcoidosis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Key Companies – Johnson and Johnson, United Therapeutics, Novartis